Center Laboratories Management
Management criteria checks 3/4
Center Laboratories' CEO is Su-Chi Wang, appointed in Oct 2023, has a tenure of 1.25 years. directly owns 0.18% of the company’s shares, worth NT$55.77M. The average tenure of the management team and the board of directors is 2 years and 3 years respectively.
Key information
Su-Chi Wang
Chief executive officer
NT$4.7m
Total compensation
CEO salary percentage | n/a |
CEO tenure | 1.3yrs |
CEO ownership | 0.2% |
Management average tenure | 2yrs |
Board average tenure | 3yrs |
Recent management updates
CEO
Su-Chi Wang
1.3yrs
Tenure
NT$4,722,000
Compensation
Ms. Su-Chi Wang is Chairman of Lumosa Therapeutics Co. Ltd. from May 14, 2024. Ms. Wang Serves as Chief Executive Officer, Operations Management Office & Investment Office at Center Laboratories, Inc. sinc...
Leadership Team
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
CEO, Chief Investment Officer | 1.3yrs | NT$4.72m | 0.18% NT$ 55.8m | |
Assistant Vice President of Legal Affairs Department | 2yrs | NT$2.30m | no data | |
General President of Pharmaceutical Business | 1.3yrs | NT$3.47m | 0.68% NT$ 211.0m | |
Head of Corporate Governance | no data | NT$1.87m | no data | |
Plant Director | 8yrs | NT$2.28m | no data | |
Manager of Finance & Accounting Department | 2.1yrs | no data | no data | |
Director of Administration Department | 26.4yrs | no data | no data |
2.0yrs
Average Tenure
Experienced Management: 4123's management team is considered experienced (2 years average tenure).
Board Members
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
CEO, Chief Investment Officer | 2.2yrs | NT$4.72m | 0.18% NT$ 55.8m | |
Independent Director | 4.6yrs | NT$735.00k | no data | |
Director | 4.6yrs | NT$55.00k | no data | |
Director | 3yrs | no data | 0.29% NT$ 90.4m | |
Director | 3yrs | no data | 0.71% NT$ 221.4m | |
Director | 2.7yrs | NT$55.00k | no data | |
Director | 3yrs | no data | no data | |
Independent Director | 3yrs | no data | no data |
3.0yrs
Average Tenure
Experienced Board: 4123's board of directors are considered experienced (3 years average tenure).
Company Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2025/01/04 07:55 |
End of Day Share Price | 2025/01/03 00:00 |
Earnings | 2024/09/30 |
Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Center Laboratories, Inc. is covered by 5 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|---|
Yenya Kuo | Capital Securities Corporation |
Regina Lee | IBTS Investment Consulting Co., Ltd. |
Li-chun Chang | Jih Sun Securities Investment Consulting Co., Ltd. |